Drug intelligence / Profile preview

Cystex Ultra Protection

Development stage: Unknown
Lead developer: Bridges
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Small Molecules, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Cystex Ultra Protection is an over-the-counter **probiotic-based urinary tract health dietary supplement** developed by Bridges Consumer Healthcare for women with recurrent urinary tract infections and for maintenance of urinary tract health. It is a **multi-ingredient combination product** containing probiotic organisms reported to have activity against common uropathogens such as *Escherichia coli* and *Enterococcus faecalis*, **36 mg cranberry proanthocyanidins** intended to reduce bacterial adhesion to the urinary tract, and **vitamin A** to support mucosal and immune function. The product also incorporates **Bio-Shield Technology** intended to protect cranberry PACs from stomach acid and improve delivery to the intestine. It is marketed as a clinically studied supplement for urinary tract support rather than as an FDA-evaluated pharmaceutical, and it is not intended to diagnose, treat, cure, or prevent disease.

Brand names: Cystex Ultra Protection
Other names: Cystex Ultra Protection probiotic-based dietary supplement

Beyond the preview

Go deeper on Cystex Ultra Protection.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cystex Ultra Protection.

Explore the full profile